Potent Anti- Trypanosoma cruzi Activities of Oxidosqualene Cyclase Inhibitors
- 1 April 2001
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 45 (4) , 1210-1215
Abstract
Trypanosoma cruzi is the protozoan agent that causes Chagas' disease, a major health problem in Latin America. Better drugs are needed to treat infected individuals. The sterol biosynthesis pathway is a potentially excellent target for drug therapy against T. cruzi . In this study, we investigated the antitrypanosomal activities of a series of compounds designed to inhibit a key enzyme in sterol biosynthesis, oxidosqualene cyclase. This enzyme converts 2,3-oxidosqualene to the tetracyclic product, lanosterol. The lead compound, N -(4 E ,8 E )-5,9, 13-trimethyl-4,8, 12-tetradecatrien-1-ylpyridinium, is an electron-poor aromatic mimic of a monocyclized transition state or high-energy intermediate formed from oxidosqualene. This compound and 27 related compounds were tested against mammalian-stage T. cruzi , and 12 inhibited growth by 50% at concentrations below 25 nM. The lead compound was shown to cause an accumulation of oxidosqualene and decreased production of lanosterol and ergosterol, consistent with specific inhibition of the oxidosqualene cyclase. The data demonstrate potent anti- T. cruzi activity associated with inhibition of oxidosqualene cyclase.Keywords
This publication has 31 references indexed in Scilit:
- Squalene Epoxidase and Oxidosqualene : Lanosterol Cyclase—Key Enzymes in Cholesterol Biosynthesis1999
- Design, synthesis and in vitro evaluation of pyridinium ion based cyclase inhibitors and antifungal agentsBioorganic & Medicinal Chemistry, 1996
- Analyzing expression of the calmodulin and ubiquitin-fusion genes ofTrypanosoma cruzi using simultaneous, independent dual gene replacementsMolecular and Biochemical Parasitology, 1994
- An experimental and clinical assay with ketoconazole in the treatment of Chagas diseaseMemórias do Instituto Oswaldo Cruz, 1993
- Cloning and characterization of the 2,3-oxidosqualene cyclase-coding gene of Candida albicansGene, 1990
- Defective sterol C5-6 desaturation and azole resistance: A new hypothesis for the mode of action of azole antifungalsBiochemical and Biophysical Research Communications, 1989
- Fl-160. A surface antigen of Trypanosoma cruzi that mimics mammalian nervous tissue.Journal of Experimental Medicine, 1989
- The activity of ketoconazole and other azoles against Trypanosoma cruzi: biochemistry and chemotherapeutic action in vitroMolecular and Biochemical Parasitology, 1989
- Biochemical and ultrastructural alterations produced by miconazole and econazole in Trypanosoma cruziMolecular and Biochemical Parasitology, 1981
- Connective Tissue Reactions in Normal and Immunized Mice to a Reticulotropic Strain of Trypanosoma CruziThe Journal of Infectious Diseases, 1955